Literature DB >> 33666046

Patients with psoriasis have a higher risk of dementia: A systematic review and meta-analysis.

Nipith Charoenngam1, Thanitsara Rittiphairoj2, Ben Ponvilawan3, Patompong Ungprasert4.   

Abstract

BACKGROUND: Patients with psoriasis may have a higher risk of dementia because of the higher inflammatory burden, although results from previous epidemiological studies have been inconsistent. AIMS: To determine the association between psoriasis and risk of dementia by pooling the evidence from previous studies.
METHODS: Potentially eligible studies were identified from Medline and EMBASE databases from inception to July 2019 using a search that comprised terms for "psoriasis" and "dementia." Studies were eligible for the meta-analysis if they were cohort studies that included psoriatic patients and individuals without psoriasis and followed them for incident dementia. Studies were also required to report standardized incidence ratio, hazard risk ratio or relative risk with related 95% confidence intervals (CI) comparing the incidence of dementia between the two cohorts. The retrieved point estimates with standard errors from each study were pooled into the final result by the random-effect model, generic inverse variance method.
RESULTS: A total of 8,861 articles were identified. After two rounds of independent review by three investigators, we included six cohort studies that met the eligibility criteria in the meta-analysis. The risk of dementia was significantly higher among psoriatic patients than in those without psoriasis with a pooled risk ratio of 1.16 (95% CI, 1.04-1.30; I2 95%). A funnel plot was relatively symmetric and was not suggestive of the presence of publication bias. LIMITATIONS: Limited accuracy of diagnosis of psoriasis and dementia as four included studies were coding-based studies, and high statistical heterogeneity among studies.
CONCLUSION: This systematic review and meta-analysis indicates that psoriatic patients have a significantly elevated risk of developing dementia.

Entities:  

Keywords:  Dementia; meta-analysis; psoriasis

Year:  2021        PMID: 33666046     DOI: 10.25259/IJDVL_732_19

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN: 0378-6323            Impact factor:   2.545


  19 in total

Review 1.  Epidemiology and risk factors of dementia.

Authors:  W M van der Flier; P Scheltens
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-12       Impact factor: 10.154

2.  Associations between specific autoimmune diseases and subsequent dementia: retrospective record-linkage cohort study, UK.

Authors:  Clare J Wotton; Michael J Goldacre
Journal:  J Epidemiol Community Health       Date:  2017-03-01       Impact factor: 3.710

3.  Dementia: assessment, management and support: summary of updated NICE guidance.

Authors:  Joshua Pink; John O'Brien; Louise Robinson; Damien Longson
Journal:  BMJ       Date:  2018-06-20

Review 4.  A clinicopathological approach to the diagnosis of dementia.

Authors:  Fanny M Elahi; Bruce L Miller
Journal:  Nat Rev Neurol       Date:  2017-07-14       Impact factor: 42.937

5.  Risk of malignancy in patients with psoriasis: a 15-year nationwide population-based prospective cohort study in Korea.

Authors:  J W Lee; K J Jung; T G Kim; M Lee; J Oh; S H Jee; M G Lee
Journal:  J Eur Acad Dermatol Venereol       Date:  2019-07-30       Impact factor: 6.166

6.  The role of peripheral inflammatory markers in dementia and Alzheimer's disease: a meta-analysis.

Authors:  Alain Koyama; Jacqueline O'Brien; Jennifer Weuve; Deborah Blacker; Andrea L Metti; Kristine Yaffe
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-09-14       Impact factor: 6.053

7.  Inflammatory markers and the risk of Alzheimer disease: the Framingham Study.

Authors:  Z S Tan; A S Beiser; R S Vasan; R Roubenoff; C A Dinarello; T B Harris; E J Benjamin; R Au; D P Kiel; P A Wolf; S Seshadri
Journal:  Neurology       Date:  2007-05-29       Impact factor: 9.910

8.  Dementia and Alzheimer's disease risks in patients with autoimmune disorders.

Authors:  Xinjun Li; Jan Sundquist; Bengt Zöller; Kristina Sundquist
Journal:  Geriatr Gerontol Int       Date:  2018-07-25       Impact factor: 2.730

Review 9.  Psoriasis: classical and emerging comorbidities.

Authors:  Maria de Fátima Santos Paim de Oliveira; Bruno de Oliveira Rocha; Gleison Vieira Duarte
Journal:  An Bras Dermatol       Date:  2015 Jan-Feb       Impact factor: 1.896

10.  Psoriasis: Epidemiology, clinical features, co-morbidities, and clinical scoring.

Authors:  Sunil Dogra; Rahul Mahajan
Journal:  Indian Dermatol Online J       Date:  2016 Nov-Dec
View more
  1 in total

Review 1.  Epidemiology of Psoriasis and Comorbid Diseases: A Narrative Review.

Authors:  Jin Bu; Ruilian Ding; Liangjia Zhou; Xiangming Chen; Erxia Shen
Journal:  Front Immunol       Date:  2022-06-10       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.